A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2004
10/07/2004	US20040198662 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders
10/07/2004	US20040198656 Methods of screening molecules that are used to prevent cardiovascular diseases
10/07/2004	US20040198654 Glucagon-like peptide-1analogs
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040198641 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders
10/07/2004	US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004	US20040197823 Compositions and methods for aa4rp assay
10/07/2004	US20040197425 by calcium-containing dietary product; metabolic consumption of adipose tissue, metabolic change, regulation of body weight, weight loss, reduced weight gain, fat loss, and reduced fat gain
10/07/2004	US20040197424 Dietary plans based on calcium
10/07/2004	US20040197423 Method of reducing risk of a weight-related health disease
10/07/2004	US20040197385 Materials and methods for regulating body weight in non-human animals
10/07/2004	US20040197383 a print describing calcium-containing dietary product and health effect of consuming a calcium-containing dietary product, the effect includes metabolic consumption of adipose tissue, metabolic change, regulation of body weight, weight loss, reduced weight gain, fat loss, and reduced fat gain
10/07/2004	US20040197382 Dairy products; calcium carbonate; adjust core temperature of individual; reducing obesity
10/07/2004	US20040197381 Enteral nutrition product and method for preparing the same
10/07/2004	US20040197380 Carbohydrate system and a method for providing nutrition to a diabetic
10/07/2004	US20040197374 Implantable pouch seeded with insulin-producing cells to treat diabetes
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents
10/07/2004	US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof
10/07/2004	CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004	CA2520147A1 Compound having affinity with calcified tissue
10/07/2004	CA2520007A1 Lipid metabolism improving agent
10/07/2004	CA2518945A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
10/06/2004	EP1464640A2 20-Epi-16-ene-25-OH-D3-analogs
10/06/2004	EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
10/06/2004	EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463801A2 Transdifferentiation of pancreatic acinar cells
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463751A2 Albumin fusion proteins
10/06/2004	EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use
10/06/2004	EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463727A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents
10/06/2004	EP1463723A1 Process for the preparation of simvastatin
10/06/2004	EP1463721A1 Compounds for imaging alzheimer's disease
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463715A1 Novel glucagon antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463563A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
10/06/2004	EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
10/06/2004	EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004	EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/06/2004	EP1307262B1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004	EP1291349B1 Malto-oligosaccharide derivatives and use thereof
10/06/2004	EP1169312B1 Glucokinase activators
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1101112B1 Leptin-mediated gene-induction
10/06/2004	EP1094797B1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels
10/06/2004	EP1032424B9 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
10/06/2004	EP0941240B1 New picornaviruses, vaccines and diagnostic kits
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene
10/06/2004	CN1535273A Novel 2,5-diazabicyclo [2.2.1] heptane derivatives
10/06/2004	CN1535271A Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/06/2004	CN1535264A Arginine derivatives
10/06/2004	CN1535261A New phenylalkyloxy-phenyl derivatives
10/06/2004	CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004	CN1535145A Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
10/06/2004	CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl}
10/06/2004	CN1535139A Atorvastatin hemi-calcium form VII
10/06/2004	CN1535116A Nutritional supplement to treat macular degeneration
10/06/2004	CN1534091A Plant vinegar health care oral liquid and its making method
10/06/2004	CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease
10/06/2004	CN1534027A New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease
10/06/2004	CN1534016A Calcium acceptor active compound
10/06/2004	CN1534010A Water soluble extract of red sage root and its preeparation method and use
10/06/2004	CN1534003A Animal and plant high effect ecological nutritive liquid and its preparation method
10/06/2004	CN1533767A Vitamic C controlled release pill and its preparation method and use
10/06/2004	CN1169825C Process for extracting triterpenic acid from gleditschia, and medical use and chinese medicine of triterpenic acid
10/06/2004	CN1169808C 'Beta'-carboline compound
10/06/2004	CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases
10/06/2004	CN1169577C Recombinant human insulin compound, its prepn and medicine composition containing the compound
10/06/2004	CN1169564C Chinese medicine for curing diabets
10/06/2004	CN1169547C Medicine for treating diabetes and its preparation method
10/06/2004	CN1169543C Blood fat reducing health care product
10/06/2004	CN1169538C Blood sugar reducing tea
10/05/2004	US6800772 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance.
10/05/2004	US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
10/05/2004	US6800632 Bicyclic inhibitors of glycogen synthase kinase 3
10/05/2004	US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea
10/05/2004	US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
10/05/2004	US6800625 For therapy of sexual dysfunction
10/05/2004	US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004	US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004	US6800607 Improved pharmacological activities, pharmacokinetics and physical properties; modified with 1-acyl-glycerol derivative
10/05/2004	US6800606 Compound having a molecular structure similar to that of human insulin, including disulphide bridges, and having insulin activity

1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 1298